Literature DB >> 20418785

Vincristine and intestinal pseudo-obstruction in children: report of 5 cases, literature review, and suggested management.

Manuel Diezi1, Andreas Nydegger, Ermindo R Di Paolo, Henri Kuchler, Maja Beck-Popovic.   

Abstract

SUMMARY: Intestinal pseudo-obstruction is a rare complication resulting from a variety of disorders. Symptoms include abdominal pain, nausea, vomiting, diarrhea, constipation, and malnutrition. Vincristine-related pseudo-obstruction has been reported in the literature, but its description in children and recommendations for management are lacking. A review of the literature revealed 21 reported pediatric cases of vincristine-related pseudo-obstruction. Most have, however, been attributed to a drug interaction with itraconazole, accidental vincristine overdose, or liver failure. Potential genetic causes are rarely addressed. We present here 5 cases of pseudo-obstruction related to vincristine without any identifiable predisposing factors, and a suggested algorithm for management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418785     DOI: 10.1097/MPH.0b013e3181d7742f

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  Pain in blood cancers.

Authors:  Pasquale Niscola; Andrea Tendas; Laura Scaramucci; Marco Giovannini; Vitaliana De Sanctis
Journal:  Indian J Palliat Care       Date:  2011-09

2.  Two cases of paralitic ileus in onco-hematologic patients.

Authors:  Francesca Carraro; Elisa Rivetti; Erica Romano; Franca Fagioli
Journal:  Pediatr Rep       Date:  2012-01-17

3.  Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat.

Authors:  Gema Vera; Ana E López-Pérez; José A Uranga; Rocío Girón; Ma Isabel Martín-Fontelles; Raquel Abalo
Journal:  Front Pharmacol       Date:  2017-02-06       Impact factor: 5.810

4.  The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo.

Authors:  Walter Blum; Thomas Henzi; László Pecze; Kim-Long Diep; Christian G Bochet; Beat Schwaller
Journal:  Oncotarget       Date:  2019-12-10

5.  Bezoar in a Pediatric Oncology Patient Treated with Coca-Cola.

Authors:  Sara Naramore; Amy Virojanapa; Moshe Bell; Punit N Jhaveri
Journal:  Case Rep Gastroenterol       Date:  2015-07-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.